Law Offices of Thomas J. Lamb

  • Asbestos & Mesothelioma
  • Benzene Diseases
  • Camp Lejeune Cases
  • Drug Injury
  • Free Case Evaluation
  • About Us

Rhabdomyolysis May Be Linked To A New Class Of Oral Diabetes Medicines

October 16, 2017 By Law Offices of Thomas J. Lamb, P.A.

A class of diabetes drugs referred to as dipeptidyl peptidase-4 inhibitors may be associated with rhabdomyolysis, a side effect which involves severe muscle damage.

In more detail, rhabdomyolysis is the breakdown of muscle tissue that leads to the release of muscle fiber contents into the blood. These substances are harmful to the kidney and often cause kidney damage.

According to a new FDA quarterly report, “Potential Signals of Serious Risks / New Safety Information Identified by the FDA Adverse Event Reporting System (FAERS): April – June 2017”, the following 13 oral diabetes medicines are being investigated for this possible rhabdomyolysis side effect:

  1. Glyxambi (empagliflozin and linagliptin) tablets
  2. Janumet (sitagliptin and metformin hydrochloride) tablets
  3. Janumet XR (sitagliptin and metformin hydrochloride extended-release) tablets
  4. Januvia (sitagliptin) tablets
  5. Jentadueto (linagliptin and metformin hydrochloride) tablets
  6. Jentadueto XR (linagliptin and metformin hydrochloride extended-release) tablets
  7. Kazano (alogliptin and metformin hydrochloride) tablets
  8. Kombiglyze XR (saxagliptin and metformin hydrochloride extended-release) tablets
  9. Nesina (alogliptin) tablets
  10. Onglyza (saxagliptin) tablets
  11. Oseni (alogliptin and pioglitazone) tablets
  12. Qtern (dapagliflozin and saxagliptin) tablets
  13. Tradjenta (linagliptin) tablets

We will be watching for reports of rhabdomyolysis in patients using Onglyza, Nesina, Januvia, and the other Type-2 diabetes drugs containing saxagliptin, alogliptin, sitagliptin, or linagliptin.

[View article at original source]

Filed Under: Unsafe Drugs Tagged With: Glyxambi, Janumet, Januvia, Jentadueto, Kazano, Kombiglyze, Nesina, Onglyza, Oseni, Qtern, Rhabdomyolysis, Tradjenta

Find What You Want Here

Get Free Case Evaluation

We encourage you to submit an online Case Evaluation Form – it is confidential and there is no obligation.

Or call our toll-free number, 800-426-9535, to speak directly to attorney Tom Lamb about your possible case.

Feel Free To Contact Us

Quick Contact Form
 
Send an Email to Tom Lamb

(800) 426-9535

Main Navigation Menu

  • About Our Firm
  • Asbestos-Mesothelioma Cases
  • Benzene Disease Claims
  • PFAS Firefighter Gear Lawsuits
  • Camp Lejeune Cases
  • GenX Water Cancer Cases
  • Drug Injury Lawsuits
  • Breast Implant Cancer Cases
  • Philips Breathing Devices Cases
  • Case Evaluation Menu
  • Quick Contact Form
  • Frequently Asked Questions
  • Medical Records Charges
  • Collection of Articles
  • Sitemap

Lamb Law Office Newsletter

Lamb Law Office Newsletter provides periodic updates about some of the cases that we are working on for clients, as well as an information resource you might find helpful.

Subscribe using Form below.

Subscription Form

* indicates required

Our Other Websites

Drug Injury Law
Drug Injury Watch
Drug Safety Developments
Asbestos & Mesothelioma

Contact Information

Law Offices of Thomas J. Lamb, P.A.
1908 Eastwood Road, Suite 225
Wilmington, North Carolina 28403
910-256-2971 | 800-426-9535
TJL@LambLawOffice.com

  • Home
  • Frequently Asked Questions
  • Disclaimer and Copyright Notices

Copyright © 2023 · Law Offices of Thomas J. Lamb, P.A.